BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/11/2021 11:07:20 AM | Browse: 302 | Download: 573
 |
Received |
|
2020-11-04 02:02 |
|
Peer-Review Started |
|
2020-11-04 02:03 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-02-12 02:20 |
|
Revised |
|
2021-02-25 09:01 |
|
Second Decision |
|
2021-03-11 13:07 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-03-12 00:38 |
|
Articles in Press |
|
2021-03-12 00:38 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-03-23 01:23 |
|
Typeset the Manuscript |
|
2021-04-30 04:36 |
|
Publish the Manuscript Online |
|
2021-05-11 11:07 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Dermatology |
| Manuscript Type |
Case Report |
| Article Title |
Recalcitrant paradoxical pustular psoriasis induced by infliximab: Two case reports
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ping Xia, Yan-Hong Li, Zhong Liu, Xu Zhang, Qian Jiang, Xiao-Yong Zhou and Wei Su |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Ministry of Science and Technology of China |
2018YFC1705304 |
| Hubei Natural Science Foundation |
2020CFB503 |
|
| Corresponding Author |
Xiao-Yong Zhou, MD, Doctor, Department of Dermatology, The First Hospital of Wuhan, No. 215 Zhongshan Avenue, Wuhan 430022, Hubei Province, China. zhouxuefeng1970@126.com |
| Key Words |
Pustular psoriasis; Paradoxical; Infliximab; Secukinumab; Ustekinumab; Anti-nuclear antibody |
| Core Tip |
In the present study, we report 2 cases of paradoxical psoriasis caused by infliximab. The data indicated that moderate to high anti-nuclear antibody titer seems to be a risk factor for paradoxical psoriasis. In addition, extensive pustular presentation might be a negative prognostic indicator and portend a protracted clinical course refractory to therapy. |
| Publish Date |
2021-05-11 11:07 |
| Citation |
Xia P, Li YH, Liu Z, Zhang X, Jiang Q, Zhou XY, Su W. Recalcitrant paradoxical pustular psoriasis induced by infliximab: Two case reports. World J Clin Cases 2021; 9(15): 3655-3661 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i15/3655.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i15.3655 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
